Jacobio Pharma throws open $173m IPO
Mainland-based Jacobio Pharmaceuticals has kicked off the roadshow for its Hong Kong listing. It is eyeing a valuation of up to HK$10.6bn ($1.37bn).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: